Stocks and Investing Stocks and Investing
Wed, August 18, 2021
Tue, August 17, 2021
Mon, August 16, 2021
Sun, August 15, 2021
Fri, August 13, 2021

Jeffrey Hung Downgraded (APRE) to Sell and Decreased Target to $60 on, Aug 13th, 2021


Published on 2024-10-27 17:39:09 - WOPRAI, Jeffrey Hung
  Print publication without navigation


Jeffrey Hung of Morgan Stanley, Downgraded "Aprea Therapeutics, Inc." (APRE) to Sell and Decreased Target from $100 to $60 on, Aug 13th, 2021.

Jeffrey, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30